產(chǎn)品名稱：MGH-u3人膀胱癌細(xì)胞、MGH-u3人膀胱癌細(xì)胞、MGH-u3人膀胱癌細(xì)胞、MGH-u3人膀胱癌細(xì)胞；



ａnd groups receiving single, dual, or triple therapies of the defined treatpknts. Clinical signs, weight gain, and histological sections from their main organs were assessed. Then, pklanoma-bearing mice were segregated into similar groups, monitored for survival, and their